Nutra Immune

NutraImmune is a biotechnology company specializing in the research and development of high-purity immunomodulating compounds, specifically Beta-1,3D Glucan. Founded on the extensive research of Dr. Vaclav Vetvicka at the University of Louisville, the company focuses on the biological effects of polysaccharides on the innate immune system. Its flagship product, Glucan #300, is a highly purified yeast-derived beta-glucan that has been the subject of numerous peer-reviewed studies for its ability to bind to specific receptors on macrophages and neutrophils. NutraImmune's work bridges the gap between basic immunological science and the commercialization of evidence-based immune support formulations. The company's products are primarily utilized as adjuncts in oncology and for general immune system enhancement.